Tumor suppressor functions of miR-133a in colorectal cancer

Molecular Cancer Research

Volumn 11, Issue 9, 2013, Pages 1051-1060

  Dong, Yujuan ^a,b   Zhao, Junhong ^a   Wu, Chung Wah ^a   Zhang, Lijing ^c   Liu, Xiaodong ^d   Kang, Wei ^a   Leung, Wing Wah ^b   Zhang, Ning ^a   Chan, Francis K L ^a   Sung, Joseph J Y ^a   Ng, Simon S M ^b   Yu, Jun ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c HEBEI MEDICAL UNIVERSITY   (China)

^d PRINCE OF WALES HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; MICRORNA; MICRORNA 133A; OXALIPLATIN; PROTEIN P53; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL ASSAY; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LASER CAPTURE MICRODISSECTION; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; TUMOR XENOGRAFT; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOGENESIS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL SURVIVAL; COLORECTAL NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DISEASE MODELS, ANIMAL; DOXORUBICIN; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MICE; MICE, NUDE; MICRORNAS; NEOPLASM TRANSPLANTATION; ORGANOPLATINUM COMPOUNDS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84884481056     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-13-0061     Document Type: Article

References (12)

1. Jemal A, Bray F, CenterMM,Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-97.
3. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalianmRNAs are conserved targets of microRNAs. Genome Res 2009;19:92-105.
4. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435:834-8. (Pubitemid 40839735)
5. Yang Y, Zhou L, Lu L, Wang L, Li X, Jiang P, et al. Anovel miR-193a-5p- YY1-APC regulatory axis in human endometrioid endometrial adenocarcinoma. Oncogene. 2012 Aug 20. [Epub ahead of print].
6. Chen WS, Leung CM, Pan HW, Hu LY, Li SC, Ho MR, et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 2006;38:228-33.
7. Georges SA, Biery MC, Kim SY, Schelter JM, Guo J, Chang AN, et al. Coordinated regulation of cell cycle transcripts by p53-inducible microRNAs, miR-192 and miR-215. Cancer Res 2008;68:10105-12.
8. McDonald ER III, El-Deiry WS. Suppression of caspase-8- and -10- associated RING proteins results in sensitization to death ligands and inhibition of tumor cell growth. Proc Natl Acad Sci U S A 2004;101: 6170-5. (Pubitemid 38520546)
9. Yang W, Rozan LM, McDonald ER III, Navaraj A, Liu JJ, Matthew EM, et al. CARPs are ubiquitin ligases that promote MDM2-independent p53 and phospho-p53ser20 degradation. J Biol Chem 2007;282: 3273-81. (Pubitemid 47084358)
10. Yang W, Dicker DT, Chen J, El-Deiry WS. CARPsenhance p53 turnover by degrading 14-3-3sigma and stabilizing MDM2. Cell Cycle 2008;7:670-82. (Pubitemid 351499007)
11. Lujambio A, Calin GA, Villanueva A, Ropero S, Sanchez-Céspedes M, Blanco D, et al. A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci U S A 2008;105: 13556-61.
12. Chen WS, Leung CM, Pan HW, Hu LY, Li SC, Ho MR, et al. Silencing of miR-1-1 and miR-133a-2 cluster expression by DNA hypermethylation in colorectal cancer. Oncol Rep 2012;28:1069-76.